edit: yes, seems it is indeed - https://news.ycombinator.com/item?id=33572721
However, it also mentions that some people need 50-60 units per meal and a vial contains 1000 units. Assuming three meals per day, someone using 50 vials per meal would spend $666.66 per month.
$666.66 per month would be prohibitively expensive for many people and even $50 to $75 could be a significant expense for people making minimum wage (depending on local minimum wage it could be equivalent to 7-8 hours of work before taxes).
https://4allfamily.com/blogs/diabetes/how-long-does-a-vial-o...
3 meals a day * 30 days would be 90 meals.
90 meals / 20 doses / 1 vial = 4.5 vials / month
4.5 * 25 = 112.5
I’m not seeing how we get to $666
Here's how I would do the math: 50 units per dose x 3.5 meals on average x 2 for basal = 350 units a day. Or 0.35 vial per day, and 10.7 vials per month. Assuming synthetic human insulin and not insulin analogue is used, that means about $270 per month.
However, some caveats:
- synthetic human insulin is not fast enough for most carbohydrates in meals, and it results in higher blood glucose spikes immediately after a meal than using an insulin analogue. The higher the blood glucose, the more insulin it takes to lower it the same amount. Moreover, we only have so many hours in the day, and slower acting synthetic human insulin needs time to work. So people using it are more likely to "overcompensate" and then eat a bit later to offset their dose. This is a very long-winded way of saying that a person might need slightly more synthetic human insulin than analogues, plus synthetic human insulin in general is less effective.
- In my calculations, I did not include correction bolus doses, insulin used to prime needles, and pump infusion sets (although probably very few people use human synthetic insulin in pumps anyways). I also did not include insulin that is spoiled in some way (refrigerator breakdowns, reserve insulin taken on trips that's not refrigerated, heatwaves, and so on).
- Most people use between 70 and 110 units of insulin per day, whether that's a combination of an insulin analogue and basal insulin injections, or using insulin analogue in a pump. I don't know how much synthetic human insulin is used per day on average, probably a bit more.
So I would say in practice, for someone who uses that much synthetic human insulin, the cost can be even $400 per month. For analogues, it would be much, much higher.
I think it makes sense for me to provide a source for all this - I care for someone with T1 diabetes and am somewhat connected with the broader T1 community.
The relatively inelastic demand of insulin analogues when synthetic human insulin is available shows how important analogues are to T1 diabetics.
Sometimes pharma companies try to allude to analogues being a luxury good compared to synthetic human insulin. But to T1 diabetics this notion is generally ridiculous. Analogue insulins allow them to regain a little bit more quality of life lost to the disease, and that should be a human right when insulin manufacturing costs are so low.
US government also represents a huge proportion of the demand but is banned through corruption from exercising similar price pressure.
Even if there is a power imbalance between Eli Lilly and the Canadian Government, there would also be a power imbalance if it was instead Eli Lilly vs. individual consumers.
Despite the skyrocketing costs of insulin over the decades, Eli Lilly’s profits per unit are mostly in line with inflation. This is because in the US system, there is a pervasive system of rebates that exists between pharmaceutical companies and insurers. Insurers often may only pay 10% of what the sticker price is for insulin. But the way these rebates get negotiated through third party firms known as PBMs create a system that incentivizes insulin that is marked up an incredible amount and then discounted to X, than simply pricing it at X in the first place. But this obviously screws over anyone without access to the rebate, i.e. those without insurance. And this system largely exists because the privatized nature of insurance in the US. If there was some kind of universal medicare in the US, undermines those incentives and the market would normalize immediately.
You don't even need that. Just more/better regulation would suffice. You have countries with fully privatized healthcare systems like Switzerland or partially privatized ones like Germany or Netherlands which have no such problems.
Which is the cornerstone of any universal healthcare system? It only works in other countries if the healthy subsidize the costs of those less fortunate.
Also Switzerland had compulsory fully private insurance. To be fair they do suffer from similar issues as the US. Healthcare prices are very inflated compared to the surrounding countries, accessibility to some services (e.g. dental) is poor for low income individuals etc.
Of course it helps that Switzerland is a quite homogenous, has low inequality and subsidize access for low income individuals. However inherently the system is not that different from the one in US (I mean Switzerland is closer to US than either is to Britain).
The companies would rather prevent Canada from funding competition, so they just jack up prices in the US to compensate.
If the US passed a law requiring sales of drugs in the US to match the lowest sale price in any other country, one of 2 things would happen.
The likely thing is that innovation would come to a standstill. Money goes to where it can make the most money. No money in drugs? No new drugs.
Or, the companies would get a lot more hard nosed about sales in countries with price controls, and there would be trade wars between the US and those countries. And then you would see higher prices in Canada.
Citation?
> so they just jack up prices in the US to compensate.
Pharmaceutical companies charge as much as they can anywhere, including in the US. They wouldn't entertain reducing prices in the US even if the Canadian market were different.
I like the innovative drugs that are being made, so I'm not in favor of price controls.
If you think drugs are too expensive, then do something about it. Create some useful drugs and sell them for a cheaper price.
That's not true. It would be the case for (close to) perfectly competitive markets with lower margins, like petrol, basic foodstuffs to some extent etc. It does not apply to markets controlled by oligopolies/monopolies. Especially pharmaceuticals where margins are extremely high and producers of some drugs would still be able to make a profit if they cut (list) prices by a magnitude or two.
Only argument against is that it might decrease available funding for developing new drugs, which might be a legitimate concern. But in no way would reasonable prices controls result in a scarcity of almost all currently available drugs.
" When inventor Frederick Banting discovered insulin in 1923, he refused to put his name on the patent. He felt it was unethical for a doctor to profit from a discovery that would save lives. Banting’s co-inventors, James Collip and Charles Best, sold the insulin patent to the University of Toronto for a mere $1. They wanted everyone who needed their medication to be able to afford it.
"
There is no "IP in Canada for Insulin given UofT "owns" the patent.
Most of the price differences between US and Canada stems from the difference in patents and trademarks. Canada has far more "Generics" vs the US.
This strikes me as odd.. but here we go...
Canada's healthcare system is the product of Tommy Douglas
https://www.cbc.ca/news/entertainment/tommy-douglas-crowned-...
" Tommy Douglas, the former Saskatchewan premier who is credited with being the founding father of Canada's health-care system, was named Monday night as the winner in the CBC's Greatest Canadian contest. "
Given Tommy Douglas was in office from 3 August 1961 – 24 April 1971 this "1947" date is unrealistic.
Most would agree this is what started Canada's health care system - Tommy's proposed "universal health care legislation in 1961."
Insulin has changed over time but the patents and the laws which govern prices in canada have been in place for a long time.
As i posted, most drugs are cheaper in canada because of the difference in US vs CA patents.
In the US you often find drugs being "reformulated" to renew the patents, this doesn't take place here.
perhaps something like this could lead to meaningful changes in the US?
https://www.fiercepharma.com/pharma/uspto-and-fda-commit-pat...
If Canada raised their insulin prices, do you think Eli Lily would lower their prices in the US?
There are pharmaceutical companies all around the world, while it's true that the US currently has the largest market cap for pharma companies, it's not like the rest of the world is sitting on it's hands. Of the top 15 largest pharmaceutical companies in the world, 8 are in the US, and 7 abroad. But market cap is a poor metric for impact, especially in the US, where it seems the market can price a social media company with no profit at 44billion, I'm not particularly convinced by valuations on pharmaceutical companies who's share pricing rely on price gouging and a indentured customer base to stay high.
Another perspective is that while they're able to sell insulin at 40x cost, something they developed decades ago, what's their incentive to develop new drugs? In countries where companies are required to provide licensing for generics after a certain time period, they would be incentivized to continue developing new drugs in order to keep products on the shelves that are in the exclusive licensing window.
Regardless of any of the above, what you're essentially advocating for is fleecing US citizens to the benefit of the rest of the world. I'm just not sure how this could possibly be a good thing for the US.
United healthcare, the largest US insurer cover over 40M people.
Are you saying that if these for-profit corporations didn't charge absurd amounts to US citizens, then the drug would be unattainable for Canadians?
The US, out of its immense generosity is subsidizing canada?
News flash, Insulin was discovered here (canada).. so how exactly are you subsidizing a Canadian discovery?
How about this for a far more realistic explanation:
" When inventor Frederick Banting discovered insulin in 1923, he refused to put his name on the patent. He felt it was unethical for a doctor to profit from a discovery that would save lives. Banting’s co-inventors, James Collip and Charles Best, sold the insulin patent to the University of Toronto for a mere $1. They wanted everyone who needed their medication to be able to afford it.
"
https://www.vox.com/2019/4/3/18293950/why-is-insulin-so-expe...
Good god some of the comments you find here are just shocking.
The insulin that is incredibly expensive these days, that people drive to Canada for, is analogue insulin, which was developed in the last several decades by the pharmaceutical companies and is far more efficacious and easy to use. It’s a completely different product, which is often missed when these discussions of the donation of the original insulin patent is brought up.
If High US prices was subsidizing others, where does the massive profit come from?
This is why drugs in the US cost so much reformulations to extend patents: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865781/
First Canada's drug administration confirms the drug is approved by the FDA and approves it for use in Canada without further test, trials, etc. Second as the production costs almost nothing any price the pharma company gets is almost pure profit. So the price in Canada ends up at $1 a tablet.
Now think what would've happened if US didn't exist. All the R&D, trials, etc. would have to be paid by all the other countries in the world. There would be far fewer new drugs being developed and they would cost a lot more.
As a Canadian, where Americans often come here in droves to buy cheap insulin i've often wondered the same thing.
https://www.ctvnews.ca/health/caravan-of-americans-cross-int...
Americans drive 1,000 KM just to get affordable insulin which in many cases is a life or death drug?